← back to search

Kamal Kant Sahu

University of Utah · US
Area of research
Pulmonary and Respiratory Medicine · Infectious Diseases
Research interest
Research interests include COVID-19 Clinical Research Studies, Prostate Cancer Treatment and Research, Cancer, Lipids, and Metabolism, and Methemoglobinemia and Tumor Lysis Syndrome.
h-index
32
citations
3,509
works
329
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Enhancing Triage Efficiency and Accuracy in Emergency Rooms for Patients with Metastatic Prostate Cancer: A Retrospective Analysis of Artificial Intelligence-Assisted Triage Using ChatGPT 4.0
Cancers 2023cited by 84position: middledoi
Update on combined immunotherapy for the treatment of advanced renal cell carcinoma
Human Vaccines & Immunotherapeutics 2023cited by 35position: middledoi
Survival outcomes of real world patients with metastatic hormone-sensitive prostate cancer who do not achieve optimal PSA response with intensified androgen deprivation therapy with docetaxel or androgen receptor pathway inhibitors
Prostate Cancer and Prostatic Diseases 2023cited by 17position: middledoi
Role of 2-Deoxy-D-Glucose (2-DG) in COVID-19 disease
Journal of Family Medicine and Primary Care 2021cited by 40position: firstdoi
Quantity does not equal quality: Scientific principles cannot be sacrificed
International Immunopharmacology 2020cited by 72position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Benjamin L. Maughan · University of Utah3 papers (2023–2023)Georges Gebrael · University of Utah3 papers (2023–2023)Neeraj Agarwal · University of Utah3 papers (2023–2023)Umang Swami · University of Utah2 papers (2023–2023)Beverly Chigarira · University of Utah2 papers (2023–2023)Nicolas Sayegh · University of Utah2 papers (2023–2023)Nishita Tripathi · Wayne State University2 papers (2023–2023)Haoran Li · University of Kansas2 papers (2023–2023)Vinay Mathew Thomas · University of Utah2 papers (2023–2023)Nima Rezaei · Lappeenranta-Lahti University of Technology1 papers (2020–2020)Gerard E. Mullin · Hebrew University of Jerusalem1 papers (2020–2020)— · 1 papers (2020–2020)Antonia Bendau · Humboldt-Universität zu Berlin1 papers (2020–2020)Hans D. Ochs · Seattle Children's Hospital1 papers (2020–2020)— · 1 papers (2020–2020)Raman Kumar · Amrita Institute of Medical Sciences and Research Centre1 papers (2021–2021)Moritz Bruno Petzold · Humboldt-Universität zu Berlin1 papers (2020–2020)Taylor Ryan McFarland · University of Utah1 papers (2023–2023)— · 1 papers (2020–2020)— · 1 papers (2020–2020)